Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination

Ryan C Neal1, Peter H Jones

  • 1Baylor College of Medicine, Section of Lipid and Atherosclerosis, Houston, TX 77030, USA. rneal@bcm.tmc.edu

Insights

New guidelines recommend lower LDL-C goals for high-risk patients. Ezetimibe/simvastatin offers an effective option for achieving these targets in cardiovascular disease management.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in the USA.
  • Declining coronary heart disease (CHD) death rates may stem from aggressive management of risk factors like hypertension, diabetes, and dyslipidemia.

Purpose of the Study:

  • To review updated National Cholesterol Education Program (NCEP) guidelines for low-density lipoprotein cholesterol (LDL-C) goals.
  • To discuss the efficacy and safety of ezetimibe/simvastatin as a lipid-lowering therapy.

Main Methods:

  • Review of updated NCEP guidelines.
  • Analysis of clinical data on ezetimibe/simvastatin efficacy and safety for LDL-C reduction.

Main Results:

  • Updated NCEP guidelines necessitate more potent lipid-lowering therapies.
  • Ezetimibe/simvastatin demonstrates efficacy in lowering LDL-C to meet new targets.

Conclusions:

  • Clinicians require effective therapies to meet new, lower LDL-C goals.
  • Ezetimibe/simvastatin is a viable option for managing high LDL-C in high-risk patients.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...